CARDIFF ONCOLOGY RECEIVES FDA FAST TRACK DESIGNATION FOR ONVANSERTIB IN FIRST-LINE RAS-MUTATED METASTATIC COLORECTAL CANCER

Reuters · 1d ago

Please log in to view news